Leonard-Meron Biosciences - Ownership and Business Overview

Life ScienceCompany

Leonard-Meron Biosciences Ownership

Who owns Leonard-Meron Biosciences?

Leonard-Meron Biosciences is owned by Citius Pharmaceuticals. It was acquired on March 7, 2016.

Leonard-Meron Biosciences Business Overview

Where is Leonard-Meron Biosciences headquartered?

Leonard-Meron Biosciences is headquartered in Cranford, New Jersey.

What sector is Leonard-Meron Biosciences in?

Leonard-Meron Biosciences is a life science company.

When was Leonard-Meron Biosciences founded?

Leonard-Meron Biosciences was founded in 2013.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 296 acquisitions of life science companies in 2016, including 34 acquisitions by private equity firms, and 262 by strategics.

Leonard-Meron Biosciences, Inc.

11 Commerce Drive,
Cranford, New Jersey 07016
United States,
(732) 425-4668

Leonard Meron Biosciences, Inc. (LMB) is a private, late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a concentration on anti-infective drugs. The Company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, or CRBSIs.


 Subscribe to unlock this and 209,748
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.